Lenox Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $4K | Sell |
49
-7
| -13% | -$571 | ﹤0.01% | 577 |
|
|
2021
Q4 | $5K | Buy |
56
+7
| +14% | +$625 | ﹤0.01% | 596 |
|
|
2021
Q3 | $4K | Hold |
49
| – | – | ﹤0.01% | 573 |
|
|
2021
Q2 | $4K | Hold |
49
| – | – | ﹤0.01% | 579 |
|
|
2021
Q1 | $4K | Hold |
49
| – | – | ﹤0.01% | 528 |
|
|
2020
Q4 | $4K | Hold |
49
| – | – | ﹤0.01% | 526 |
|
|
2020
Q3 | $4K | Hold |
49
| – | – | ﹤0.01% | 452 |
|
|
2020
Q2 | $6K | Hold |
49
| – | – | ﹤0.01% | 413 |
|
|
2020
Q1 | $4K | Hold |
49
| – | – | ﹤0.01% | 444 |
|
|
2019
Q4 | $4K | Hold |
49
| – | – | ﹤0.01% | 496 |
|
|
2019
Q3 | $3K | Hold |
49
| – | – | ﹤0.01% | 442 |
|
|
2019
Q2 | $4K | Hold |
49
| – | – | ﹤0.01% | 324 |
|
|
2019
Q1 | $4K | Hold |
49
| – | – | ﹤0.01% | 389 |
|
|
2018
Q4 | $4K | Hold |
49
| – | – | ﹤0.01% | 295 |
|
|
2018
Q3 | $5K | Hold |
49
| – | – | ﹤0.01% | 306 |
|
|
2018
Q2 | $5K | Hold |
49
| – | – | ﹤0.01% | 451 |
|
|
2018
Q1 | $4K | Buy |
+49
| New | +$4K | ﹤0.01% | 429 |
|